돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1486466생성일: 2026년 10월 23일

Acetamide → 3,5-Diiodothyronine, L-

https://huagongshe.com/ko/reaction/1486466

반응식

참여 물질

역할이름HCID투입량
반응물AcetamideHCID 178—
반응물Hydrogen BromideHCID 260—
반응물Dimethyl EtherHCID 8254—
반응물Hydrogen iodideHCID 24841—
반응물L-Tyrosine, N-acetyl-3,5-diiodo-O-(4-methoxyphenyl)-, ethyl esterHCID 10952191—
생성물3,5-Diiodothyronine, L-HCID 92859—

반응 단계

Many patent and non-patent literature describe the use of an intermediate called Bis (p-anisyl)iodonium bromide in the preparation of Levothyroxine sodium. Hillmann (Z. Naturforch 1956; 11b:424-425) describes a process for the assembly of the biphenyl-ether system present in Levothyroxine, wherein a key coupling reaction is initiated between N-Acetyl 3,5-diiodo-L-tyrosine ethyl ester, derived from the stepwise protective conversion of amine as amide and acid as ester of 3,5 diido-L-tyrosine, and Bis (p-anisyl)iodonium bromide in the presence of copper metal or powder as a catalyst to afford (S)—N-acetyl-3,5-diiodo-4-p-methoxyphenoxyphenylalanine ethyl ester, with 87% yield. All the three protective groups in (S)—N-acetyl-3,5-diiodo-4-p-methoxyphenoxyphenylalanine ethyl ester, viz. acetamide, methyl ether, ethyl ester were cleaved using a mixture of Hydroiodic acid and Hydrobromic acid to give 3,5-Diiodothyronine. 3,5-Diiodothyronine on subsequent iodination with iodine gave L-thyroxine of an yield that corresponds to 92%.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US09428444B2
출처 데이터셋uspto-grants-2016_08
ORD IDord-19dc8d269fa84dfbaa970919e8c7f67c
출처 메모uspto-grants-2016_08